These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 7731937

  • 1. Prognostic significance of cellular proliferation in renal cell carcinoma: a comparison of synthesis-phase fraction and proliferating cell nuclear antigen index.
    Grignon DJ, Abdel-Malak M, Mertens W, Koster J, Keeney M, Sakr W, Shepherd RR.
    Mod Pathol; 1995 Jan; 8(1):18-24. PubMed ID: 7731937
    [Abstract] [Full Text] [Related]

  • 2. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P.
    Scand J Urol Nephrol Suppl; 1994 Jan; 165():1-48. PubMed ID: 7871395
    [Abstract] [Full Text] [Related]

  • 3. A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction.
    Nordström B, Strang P, Bergström R, Nilsson S, Tribukait B.
    Cancer; 1996 Nov 01; 78(9):1942-51. PubMed ID: 8909315
    [Abstract] [Full Text] [Related]

  • 4. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
    Crucitti A, Masetti R, Breccia C, Coppola R, Magistrelli P, Nuzzo G, Maggiano N, Picciocchi A.
    Hepatogastroenterology; 1999 Nov 01; 46(26):1187-91. PubMed ID: 10370689
    [Abstract] [Full Text] [Related]

  • 5. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
    Belessi CJ, Parasi AS, Manioudaki HS, Laoutaris NP, Legakis NC, Peros GT, Androulakis GA.
    J Surg Oncol; 2003 Apr 01; 82(4):247-55. PubMed ID: 12672009
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
    Tanioka F, Hiroi M, Yamane T, Hara H.
    Zentralbl Pathol; 1993 Aug 01; 139(3):185-93. PubMed ID: 8105885
    [Abstract] [Full Text] [Related]

  • 12. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
    Chae YS, Flotte T, Hsu DW, Preffer F, Hedley-Whyte ET.
    Gen Diagn Pathol; 1996 Oct 01; 142(2):89-95. PubMed ID: 8950573
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis.
    Cheville JC, Terrell RB, Cohen MB.
    Mod Pathol; 1994 Sep 01; 7(7):794-800. PubMed ID: 7824516
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Needle biopsy of hepatocellular carcinoma: assessment of prognostic contribution of histologic parameters including proliferating cell nuclear antigen labeling and correlations with clinical outcomes. Group d'Etude et de Traitement du Carcinoma Hépatocellulaire.
    Chapel F, Guettier C, Chastang C, Rached AA, Mathieu D, Tepper M, Beaugrand M, Trinchet JC.
    Cancer; 1996 Mar 01; 77(5):864-71. PubMed ID: 8608476
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Correlations of morphology, proliferation indices, and oncogene activation in ductal breast carcinoma: nuclear grade, S-phase, proliferating cell nuclear antigen, p53, epidermal growth factor receptor, and c-erb-B-2.
    Dabbs DJ.
    Mod Pathol; 1995 Aug 01; 8(6):637-42. PubMed ID: 8532697
    [Abstract] [Full Text] [Related]

  • 20. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
    Pinto AE, Cabeçadas J, Nóbrega SD, Mendonça E.
    Diagn Cytopathol; 2003 Oct 01; 29(4):194-9. PubMed ID: 14506670
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.